You’ve heard of on-demand TV, now imagine on-demand medical diagnosis – anytime, anywhere in the world. Scientists at GE Global Research, the technology development arm of the General Electric Co. (NYSE: GE), are working with a team based at the University of Washington to develop a new medical device, the size of a pack of playing cards, that can detect infectious disease by way of a simple nasal swab, in less than an hour. See a video simulation of how such a device could work and hear from GE’s lead researcher by going to http://youtu.be/jJVgIIee2xM.
“We live in an on-demand world, where news and information is instantaneous. We’ve asked why the same can’t be done for diagnosing infectious diseases where early detection is so critical to positive patient outcomes,” said David Moore, Manager of the Membrane and Separation Technologies Lab at GE Global Research and Co-Principal Investigator on the project. “As part of our program with DARPA, we’re developing a small, light-weight device that a doctor could fit in their pocket. This unit could readily detect multiple pathogens in limited resource settings, such as military outposts or communities in remote areas.”
GE is conducting the research jointly with a team led by Prof. Paul Yager, Chair of Bioengineering at the University of Washington. "We're very excited about this team's unique ability to combine new designs for paper-based microfluidics with new nucleic amplification methods and GE's novel paper chemistries to help develop the first fully-disposable versatile pathogen identification technology for use in the developed and developing worlds, " said Yager
Other collaborators in the project, which is funded by an 18-month, $9.6 million grant from the Defense Advanced Research Projects Agency (DARPA), include Seattle Children’s, Epoch Biosciences, and PATH. The focus is the development of instrument-free nucleic acid amplification for pathogen identification. The team was previously awarded a DARPA grant for $4 million, and is also funded by an ongoing $5.7 million grant from the National Institutes of Health (NIH) that focuses on immunoassay development for detection of influenza.
Select the service that is right for you!COMPARE ALL SERVICES
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
- Real Money + Doug Kass Plus 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV